News, Research & Development

Ebola vaccine efficacy trial ready to launch in Guinea

The vaccine was developed by the Public Health Agency of Canada. A second vaccine will be tested in a sequential study, as supply becomes available. The trial is funded by MSF; the Research Council of Norway through Norway’s Institute of...

The vaccine was developed by the Public Health Agency of Canada. A second vaccine will be tested in a sequential study, as supply becomes available.

The trial is funded by MSF; the Research Council of Norway through Norway’s Institute of Public Health; the Canadian government through the Public Health Agency of Canada, Canadian Institutes of Health Research, International Development Research Centre and Department of Foreign Affairs, Trade and Development; and WHO, with support from the Wellcome Trust, United Kingdom.

Press Release from World Health Organization